'Super high-flux' or 'high cut-off' hemofiltration and hemodialysis

Contributions to Nephrology

Volumn 166, Issue , 2010, Pages 181-189

  Naka, Toshio ^a   Haase, Michael ^b   Bellomo, Rinaldo ^c,d  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CYTOKINE;

ARTIFICIAL MEMBRANE; BLOOD; HEMODYNAMICS; HEMOFILTRATION; HUMAN; IMMUNITY; INSTRUMENTATION; ISOLATION AND PURIFICATION; RENAL REPLACEMENT THERAPY; REVIEW;

CYTOKINES; HEMODYNAMICS; HEMOFILTRATION; HUMANS; IMMUNITY; INFLAMMATION MEDIATORS; MEMBRANES, ARTIFICIAL; RENAL DIALYSIS;

EID: 77955881855     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000314871     Document Type: Article

References (29)

1. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003;31:946-945.
2. Bagshaw SM, Laupland KB, Doig CJ, et al: Prognosis for long term survival and renal recovery in critically ill patients with severe acute renal failure : a population based study. Crit Care 2005;9: R700-R709.
3. Thijs LG, Hack CE: Time course of cytokine levels in sepsis. Intensive Care Med 1995;21: s258-s263.
4. Van Dissel JT, Van Langevelde P, Westendrop RG, et al: Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 1998;351:950-953.
5. Uchino S, Bellomo R, Goldsmith D, et al: Super high flux hemofiltration : a new technique for cytokine removal. Intensive Care Med 2002;28:651-655.
6. Morgera S, Klonower D, Rocktaschel J, et al: TNF-á elimination with high cut-off haemofilters : a feasible clinical modality for septic patients? Nephrol Dial Transplant 2003;18:1361-1369.
7. Haase M, Bellomo R, Morgera S, et al: High cut-off point membranes in septic acute renal failure : a systematic review. Int J Artif Organs 2007;30:1031-1041.
8. Honore PM, Matson JR: Hemofiltration, adsorption, sieving and the challenge of sepsis therapy design. Crit Care 2002;6:394-396.
9. Hoffmann J, Werdan K, Hartl W, et al: Hemofiltration from patients with severe sepsis and depressed left ventricular contractility contains cardiotoxic compounds. Shock 1999;12:174-180.
10. Heering P, Morgera S, Schmitz F, et al: Cytokine removal and cardiovascular hemodynamics in septic patients with continuous veno-venous hemofiltration. Intensive Care Med 1997;23:288-296.
11. De Vriese A, Colardyn F, Philippe JJ, et al: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-853.
12. Uchino S, Bellomo R, Goldsmith D, et al: Cytokine removal with a large pore cellulose triacetate filter : an ex vivo study. Int J Artif Organs 2002;25:27-32.
13. Morgera S, Haase M, Kuss T, et al: Pilot study on the effects of high cutoff hemofiltration on the need for norepinephrine in septic patients with acute renal failure. Crit Care Med 2006;34:2099-2104.
14. Morgera S, Slowinski T, Melzer C, et al: Renal replacement therapy with high-cutoff hemofilters : impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004;43:444-453.
15. Lee WC, Uchino S, Fealy N, et al: Super high flux hemodialysis at high dialysate flows : an ex vivo assessment. Int J Artif Organs 2004;27:24-28.
16. Morgera S, Rocktaschel J, Haase M, et al: Intermittent high permeability hemofiltration in septic patients with acute renal failure. Intensive Care Med 2003;29:1989-1995.
17. Bordoni V, Bolgan I, Brendolan A, et al: Caspase-3 and-8 activation and cytokine removal with a novel cellulose triacetate super-permeable membrane in an in vitro sepsis model. Int J Artif Organs 2003;26:897-905.
18. Morgera S, Haase M, Rocktaschel J, et al: High permeability haemofiltration improves peripheral blood mononuclear cell proliferation in septic patients with acute renal failure. Nephrol Dial Transplant 2003;18:2570-2576.
19. Morgera S, Haase M, Rocktaschel J, et al: Intermittent high-permeability hemofiltration modulates inflammatory response in septic patients with multiorgan failure. Nephron Clin Pract 2003;94: c75-c80.
20. Morgera S, Slowinski T, Melzer C, et al: Renal replacement therapy with high-cutoff hemofilters : impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004;43:444-453.
21. Uchino S, Bellomo R, Morimatsu H, et al: Cytokine dialysis : an ex vivo study. ASAIO J 2002;48:650-653.
22. 2-microglobulin clearance with super high flux hemodialysis : an ex vivo study. Int J Artif Organs 2003;26:723-727.
23. Lee WCR, Uchino S, Fealy N, et al: Super high flux hemodialysis at high dialysate flows : an ex vivo assessment. Int J Artif Organs 2004;27:24-28.
24. Lee D, Haase M, Haase-Fielitz A, et al: A pilot, randomized, double-blind, cross-over study of high cut-off versus high-flux dialysis membranes. Blood Purif 2009;28:365-372.
25. Haase M, Bellomo R, Baldwin I, et al: Hemodialysis membrane with a highmolecularweight cut-off and cytokine levels in sepsis complicated by acute renal failure : A phase 1 randomized trial. Am J Kidney Dis 2007;50:296-304.
26. Parrish WR, Gallowitsh-Puerta M, Czura CJ, et al: Experimental therapeutic strategies for severe sepsis. Ann NY Acad Sci 2008;1144:210-236.
27. Mantell LL, Parrish WR, Ulloa L: HMGB-1 as a therapeutic target for infectious and inflammatory disorders. Shock 2006;25:4-11.
28. Wang H, Bloom O, Zhang M, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999;285:248-251.
29. Kim JY, Park JS, Strassheim D, et al: HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 2005;288: L958-L965.